SCHEMBL8545455

SCHEMBL8545455

c1cncc(-c2cc(C3CCN(CCc4c[nH]c5ccccc45)CC3)n[nH]2)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.50
DRD4 P21917 3/20 0.50
HTR2A P28223 1/20 0.48
HTR1A P08908 5/20 0.46
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CDK4 P11802 1/20 0.43
CCND1 P24385 1/20 0.43
HTR1D P28221 2/20 0.42
HTR1B P28222 2/20 0.42
DRD3 P35462 2/20 0.42
DRD1 P21728 1/20 0.42
DRD5 P21918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549897 0.85 DRD2 (0.52) DRD2DRD4HTR1ADRD3
SCHEMBL8548381 0.83 DRD2 (0.49) DRD2DRD4HTR2AHTR1ADRD3
SCHEMBL8551091 0.81 HTR1A (0.53) DRD2HTR2AHTR1AADRA2AADRA2B
SCHEMBL8590734 0.81 DRD2 (0.51) DRD2DRD4HTR1A
SCHEMBL8547063 0.79 DRD4 (0.57) DRD2DRD4HTR1ADRD3
SCHEMBL8551088 0.78 HTR2A (0.42) DRD2DRD4HTR2AHTR1AADRA2A
SCHEMBL8545948 0.76 DRD2 (0.50) DRD2DRD4HTR2AHTR1AADRA2A
SCHEMBL8550207 0.76 DRD2 (0.56) DRD2DRD4HTR1ADRD3
SCHEMBL1388497 0.76 DRD2 (0.56) DRD2DRD4HTR2AHTR1AADRA2A
SCHEMBL8592270 0.74 DRD2 (0.55) DRD2DRD4HTR1ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP claimed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP claimed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO claimed
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP disclosed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP disclosed
US-5668148-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1997-09-16 US disclosed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO disclosed